search
close_mark

Stef Schutte

Stef Schutte

02 Dec, 2025

With 30+ years in pharma, Stef has led global Regulatory Affairs at Astellas and served as Head of RA-EMEA at Merck (MSD), advancing development, approvals, and compliance across international markets. Extensive experience in strengthening regulatory operations, accelerating product development pathways, and building high-performing teams.

Other Related Articles

How Large Portfolios Can Stay Audit-Ready with Correct, Continuous, and Consistent CER Maintenance
Blog Medical Devices

How Large Portfolios Can Stay Audit-Ready with Correct, Continuous, and Consistent CER Maintenance

08 Jan, 2026

AI and Automation in Clinical Evaluation Reports (CERs): From Burden to Breakthrough
Blog Medical Devices

AI and Automation in Clinical Evaluation Reports (CERs): From Burden to Breakthrough

23 Dec, 2025

CMC Technical Writing: Strengthening Change Control and Lifecycle Management
Blog Pharmaceutical

CMC Technical Writing: Strengthening Change Control and Lifecycle Management

16 Dec, 2025

EUDAMED Becomes Fully Mandatory from 28 May 2026: What Medical Device & IVD Manufacturers Need to Know
Blog Medical Devices

EUDAMED Becomes Fully Mandatory from 28 May 2026: What Medical Device & IVD Manufacturers Need to Know

08 Dec, 2025

CMC Technical Writing: A Critical Enabler During Product Development
Blog Pharmaceutical

CMC Technical Writing: A Critical Enabler During Product Development

02 Dec, 2025

AI in Medical and Technical Writing: Moving Beyond the Hype to Real-World Impact
Blog Medical Devices

AI in Medical and Technical Writing: Moving Beyond the Hype to Real-World Impact

20 Nov, 2025

What is a Service+Tech Model? – The Fastest Path to Integrating AI into Regulatory Operations
Blog Medical Devices

What is a Service+Tech Model? – The Fastest Path to Integrating AI into Regulatory Operations

11 Nov, 2025

From Spreadsheets to Strategic Assets: Key Takeaways from Our Regulatory Data Management Webinar
Blog Pharmaceutical

From Spreadsheets to Strategic Assets: Key Takeaways from Our Regulatory Data Management Webinar

04 Nov, 2025

View All